SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-21-299386
Filing Date
2021-10-15
Accepted
2021-10-15 07:15:41
Documents
15
Period of Report
2021-10-15

Document Format Files

Seq Description Document Type Size
1 6-K d229129d6k.htm 6-K 11794
2 EX-99.1 d229129dex991.htm EX-99.1 54048
3 EX-99.2 d229129dex992.htm EX-99.2 15083
4 EX-99.3 d229129dex993.htm EX-99.3 61611
5 EX-99.4 d229129dex994.htm EX-99.4 149450
6 EX-99.5 d229129dex995.htm EX-99.5 84889
7 GRAPHIC g229129dsp050.jpg GRAPHIC 2311
8 GRAPHIC g229129dsp052.jpg GRAPHIC 298356
9 GRAPHIC g229129dsp053.jpg GRAPHIC 198797
10 GRAPHIC g229129dsp054.jpg GRAPHIC 196658
11 GRAPHIC g229129dsp055.jpg GRAPHIC 236915
12 GRAPHIC g229129g1014235028399.jpg GRAPHIC 3536
13 GRAPHIC g229129g1015000139134.jpg GRAPHIC 3536
14 GRAPHIC g229129g1015000659183.jpg GRAPHIC 3499
15 GRAPHIC g229129g1015000659339.jpg GRAPHIC 3238
  Complete submission text file 0001193125-21-299386.txt   1683366
Mailing Address 72 HAMMERSMITH ROAD LONDON X0 W14 8TH
Business Address 72 HAMMERSMITH ROAD LONDON X0 W14 8TH 44-0-20-3457 6900
Silence Therapeutics plc (Filer) CIK: 0001479615 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0
Type: 6-K | Act: 34 | File No.: 001-39487 | Film No.: 211324782
SIC: 2834 Pharmaceutical Preparations